S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12

Aurora Cannabis Stock Forecast, Price & News

$7.03
-0.15 (-2.09 %)
(As of 10/26/2021 04:00 PM ET)
Add
Compare
Today's Range
$6.88
$7.27
50-Day Range
$5.95
$7.44
52-Week Range
$3.71
$18.98
Volume5.37 million shs
Average Volume10.83 million shs
Market Capitalization$1.39 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.1
30 days | 90 days | 365 days | Advanced Chart
Receive ACB News and Ratings via Email

Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter.


Aurora Cannabis logo

About Aurora Cannabis

Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Employees
1,761
Year Founded
N/A

Sales & Book Value

Annual Sales
$191.43 million
Book Value
$8.03 per share

Profitability

Net Income
$-542.59 million
Net Margins
-285.74%

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$1.39 billion
Next Earnings Date
11/8/2021 (Estimated)
Optionable
Optionable

MarketRank

Overall MarketRank

1.40 out of 5 stars

Medical Sector

1084th out of 1,363 stocks

Medicinals & Botanicals Industry

13th out of 19 stocks

Analyst Opinion: 1.8Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -












Aurora Cannabis (NYSE:ACB) Frequently Asked Questions

Is Aurora Cannabis a buy right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last twelve months. There are currently 6 sell ratings and 6 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Aurora Cannabis stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACB, but not buy additional shares or sell existing shares.
View analyst ratings for Aurora Cannabis
or view top-rated stocks.

What stocks does MarketBeat like better than Aurora Cannabis?

Wall Street analysts have given Aurora Cannabis a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aurora Cannabis wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Aurora Cannabis' next earnings date?

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.
View our earnings forecast for Aurora Cannabis
.

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc. (NYSE:ACB) posted its earnings results on Monday, September, 27th. The company reported ($0.21) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.22) by $0.01. The company had revenue of $44.63 million for the quarter, compared to the consensus estimate of $45.91 million. Aurora Cannabis had a negative net margin of 285.74% and a negative trailing twelve-month return on equity of 12.68%.
View Aurora Cannabis' earnings history
.

How has Aurora Cannabis' stock been impacted by COVID-19?

Aurora Cannabis' stock was trading at $10.3044 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ACB shares have decreased by 31.8% and is now trading at $7.03.
View which stocks have been most impacted by COVID-19
.

When did Aurora Cannabis' stock split? How did Aurora Cannabis' stock split work?

Shares of Aurora Cannabis reverse split on Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 8th 2020. An investor that had 100 shares of Aurora Cannabis stock prior to the reverse split would have 8 shares after the split.

What price target have analysts set for ACB?

12 brokerages have issued 12-month price targets for Aurora Cannabis' shares. Their forecasts range from $3.60 to $8.30. On average, they anticipate Aurora Cannabis' stock price to reach $6.71 in the next year. This suggests that the stock has a possible downside of 4.6%.
View analysts' price targets for Aurora Cannabis
or view top-rated stocks among Wall Street analysts.

Who are Aurora Cannabis' key executives?

Aurora Cannabis' management team includes the following people:
  • Miguel Martin, CEO, Director & Chief Commercial Officer
  • Glen W. Ibbott, Chief Financial Officer
  • Darryl Vleeming, Chief Information Officer
  • Nick Whitehead, Senior Vice President-Market Development
  • André Jerome, Executive VP-Global Business Development

What other stocks do shareholders of Aurora Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include (CGC), Cronos Group (CRON), (APHA), NVIDIA (NVDA), (HEXO), Tilray (TLRY), Alibaba Group (BABA), Advanced Micro Devices (AMD), General Electric (GE) and Micron Technology (MU).

What is Aurora Cannabis' stock symbol?

Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB."

Who are Aurora Cannabis' major shareholders?

Aurora Cannabis' stock is owned by many different institutional and retail investors. Top institutional shareholders include Greenwich Wealth Management LLC (0.05%), Kessler Investment Group LLC (0.02%), Foundations Investment Advisors LLC (0.02%), Private Advisor Group LLC (0.01%) and Kestra Advisory Services LLC (0.01%).

Which institutional investors are selling Aurora Cannabis stock?

ACB stock was sold by a variety of institutional investors in the last quarter, including Kessler Investment Group LLC.

Which institutional investors are buying Aurora Cannabis stock?

ACB stock was purchased by a variety of institutional investors in the last quarter, including Greenwich Wealth Management LLC, Kestra Advisory Services LLC, Foundations Investment Advisors LLC, and Private Advisor Group LLC.

How do I buy shares of Aurora Cannabis?

Shares of ACB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aurora Cannabis' stock price today?

One share of ACB stock can currently be purchased for approximately $7.03.

How much money does Aurora Cannabis make?

Aurora Cannabis has a market capitalization of $1.39 billion and generates $191.43 million in revenue each year. The company earns $-542.59 million in net income (profit) each year or ($1.85) on an earnings per share basis.

How many employees does Aurora Cannabis have?

Aurora Cannabis employs 1,761 workers across the globe.

What is Aurora Cannabis' official website?

The official website for Aurora Cannabis is auroramj.com.

Where are Aurora Cannabis' headquarters?

Aurora Cannabis is headquartered at 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6.

How can I contact Aurora Cannabis?

Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company can be reached via phone at (855) 279-4652 or via email at [email protected].


This page was last updated on 10/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.